120mg Belzutifan $50

Belzutifan is a drug that specifically blocks VHL-associated RCC by targeting HIF-2. It helps to cut down on the signals that cause tumors to become low on oxygen.

The medication is available in the form of 40 mg film-coated tablets, with a recommended daily dose of 120 mg taken once per day. One bottle has enough tablets for about a month.